A 58-year-old woman with a 35 pack-year smoking history presents with chronic productive cough, recurrent lower respiratory tract infections, and mild dyspnea. On examination, she has coarse crackles at the lung bases and mild cyanosis. Spirometry shows FEV₁/FVC of 0.65 and FEV₁ of 52% predicted. High-resolution CT chest reveals bronchial wall thickening and bronchus-to-artery ratio >1 in multiple segments, with minimal emphysema. Sputum culture grows Haemophilus influenzae. Which pathological feature is MOST prominent in this patient's airway disease?

Explanation

## Chronic Bronchitis Pathology: Mucus Gland Hyperplasia ### Diagnostic Criteria for Chronic Bronchitis **Key Point:** Chronic bronchitis is defined **clinically** as productive cough for ≥3 months per year for ≥2 consecutive years. The **pathological hallmark** is **mucus gland hyperplasia** with increased mucin-secreting goblet cells in the bronchial walls. ### Pathological Changes in Chronic Bronchitis 1. **Mucus gland hyperplasia** — Increased number and size of mucus glands in the bronchial submucosa 2. **Goblet cell metaplasia** — Squamous epithelium is replaced by mucin-secreting goblet cells 3. **Reid index elevation** — The Reid index (ratio of mucus gland layer thickness to total bronchial wall thickness) is >0.5 in chronic bronchitis (normal <0.4) 4. **Chronic airway inflammation** — Infiltration by lymphocytes, macrophages, and neutrophils 5. **Bronchial wall thickening** — Due to smooth muscle hypertrophy and fibrosis ### Clinical-Pathological Correlation in This Patient **Clinical Pearl:** The **bronchus-to-artery ratio >1** on HRCT is a radiological sign of bronchial wall thickening and is characteristic of chronic bronchitis. In normal lungs, the bronchus-to-artery ratio is <1. **High-Yield:** The **coarse crackles at lung bases** reflect retained secretions in the airways — a direct consequence of mucus gland hyperplasia and impaired mucociliary clearance. **Mnemonic:** **GRIM** — Gland hyperplasia, Reid index elevation, Inflammation, Mucus plugging in chronic bronchitis. ### Comparison: Emphysema vs. Chronic Bronchitis | Feature | Emphysema | Chronic Bronchitis | COPD (Mixed) | | --- | --- | --- | --- | | **Primary pathology** | Alveolar wall destruction, elastic fiber loss | Mucus gland hyperplasia, goblet cell metaplasia | Both | | **Reid index** | Normal (<0.4) | Elevated (>0.5) | Elevated | | **Bronchus-to-artery ratio** | Normal (<1) | Elevated (>1) | Elevated | | **Emphysema on imaging** | Prominent | Minimal or absent | Variable | | **Airway narrowing mechanism** | Elastic recoil loss, airway collapse | Mucus plugging, airway wall thickening | Both | | **Reversibility** | Irreversible | Partially reversible | Largely irreversible | | **Bronchodilator response** | Poor | Better | Poor | | **Recurrent infections** | Less common | Common (due to mucus stasis) | Common | ### Why This Patient Has Chronic Bronchitis Phenotype 1. **Productive cough with mucoid sputum** — Reflects mucus gland hyperplasia 2. **Recurrent infections** (H. influenzae) — Stagnant mucus provides a nidus for bacterial colonization 3. **Minimal emphysema on HRCT** — Alveolar destruction is not the dominant pathology 4. **Bronchial wall thickening** — Visible on HRCT as elevated bronchus-to-artery ratio 5. **Mild cyanosis** — Suggests ventilation-perfusion mismatch from airway obstruction and mucus plugging ### Mucus Gland Hyperplasia: Mechanism **Key Point:** Chronic cigarette smoke exposure triggers: 1. **Epithelial injury** → Loss of ciliated columnar cells 2. **Metaplasia** → Replacement by mucin-secreting goblet cells 3. **Gland proliferation** → Increased mucus gland size and number in the submucosa 4. **Impaired clearance** → Ciliary dysfunction + increased mucus volume = retained secretions ### Clinical Implications **Clinical Pearl:** Patients with **chronic bronchitis phenotype** often respond better to: - Mucolytics (N-acetylcysteine, carbocisteine) to thin secretions - Airway clearance techniques (chest physiotherapy, oscillatory positive expiratory pressure) - Bronchodilators (to improve airflow and clearance) - Prophylactic antibiotics (to prevent recurrent infections) They may show **greater bronchodilator reversibility** than emphysema-dominant COPD because the obstruction is partly due to reversible mucus plugging and airway wall edema. [cite:Robbins 10e Ch 15]